Last reviewed · How we verify

NCT05099653: APMICI

Study of the Impact of a Physical Activity Programme on the Quality of Life of Patients With Inflammatory Bowel Disease

Status unknown NA Last updated 5 May 2022
What this trial tests

NA trial testing physical activity in Crohn Disease Haemorrhagic Rectocolitis in 30 participants. Status unknown.

Timeline
20 February 2020
Primary endpoint
31 October 2022
31 October 2022

Quick facts

Lead sponsorRaincy Montfermeil Hospital Group
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment30
Start date20 February 2020
Primary completion31 October 2022
Estimated completion31 October 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Raincy Montfermeil Hospital Group

Who can join

18 and older, any sex, with Crohn Disease Haemorrhagic Rectocolitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Regular physical activity at a mild to moderate intensity can control inflammation in general and intestinal inflammation in particular during IBD. The effectiveness of a physical activity programme has been evaluated during IBD, but the data are limited to a few studies. Overall, PA improves quality of life but also improves control of disease symptoms and fatigue . The aim of the present work is to evaluate the impact of a physical activity programme on quality of life in patients with IBD. This programme will also evaluate the impact of physical activity on 1) anxiety-depression, 2) fatigue (a frequent and difficult to manage symptom in IBD), 3) IBD activity, 4) smoking cessation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of physical activity

Trials testing the same drug.

Other Raincy Montfermeil Hospital Group trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05099653.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing